En Face Spectral-Domain Optical Coherence Tomography Imaging of Outer Retinal Hard Exudates in Diabetic Macular Edema Based on Optical Coherence Tomography Patterns

被引:8
作者
Kim, Yonguk [1 ]
Yu, Seung-Young [1 ]
Kwak, Hyung Woo [1 ]
机构
[1] Kyung Hee Univ, KyungHee Univ Hosp, Dept Ophthalmol, Seoul, South Korea
关键词
INTRAVITREAL RANIBIZUMAB; RETINOPATHY; IMAGES; MACULOPATHY;
D O I
10.3928/23258160-20160324-02
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background and Objective: To evaluate en face spectral-domain optical coherence tomography (SD-OCT) findings of the outer retinal hard exudates in diabetic macular edema (DME). Patients and Methods: Exploratory analyses of prospective and consecutive case series. Fifty-five eyes treated with intravitreal ranibizumab (IVR) (Lucentis; Genentech, South San Francisco, CA) for 12 months were classified according to OCT features of DME: diffuse retinal thickening (DRT), cystoid macular edema (CME), and serous retinal detachment (SRD). Area fraction of outer nuclear layer (ONL) hard exudates (HEs) was assessed from en face OCT images. Results: Area fraction of ONL HEs increased from 1.45% +/- 1.22% to 2.24% +/- 1.31% in DRT and from 2.24% +/- 1.85% to 3.25% +/- 1.52% in CME. HE gain was greatest during first 3 months (DRT = 0.83%; CME = 1.25%). SRD showed no difference in HEs (P = .462). Conclusions: ONL HEs increased in DRT and CME at month 12 following IVR. Rapid gain of HEs was found during the initial loading phase of IVR.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 22 条
[1]   Pathomechanisms of cystoid macular edema [J].
Bringmann, A ;
Reichenbach, A ;
Wiedemann, P .
OPHTHALMIC RESEARCH, 2004, 36 (05) :241-249
[2]   Effects of Intravitreal Ranibizumab on Retinal Hard Exudate in Diabetic Macular Edema Findings from the RIDE and RISE Phase III Clinical Trials [J].
Domalpally, Amitha ;
Ip, Michael S. ;
Ehrlich, Jason S. .
OPHTHALMOLOGY, 2015, 122 (04) :779-786
[3]   Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results [J].
Elman, Michael J. ;
Ayala, Allison ;
Bressler, Neil M. ;
Browning, David ;
Flaxel, Christina J. ;
Glassman, Adam R. ;
Jampol, Lee M. ;
Stone, Thomas W. .
OPHTHALMOLOGY, 2015, 122 (02) :375-381
[4]   Subretinal fibrosis in diabetic macular edema - ETDRS report 23 [J].
Fong, DS ;
Segal, PP ;
Myers, F ;
Ferris, FL ;
Hubbard, LD ;
Davis, MD .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (07) :873-877
[5]   QUANTITATIVE ASSESSMENT OF MACULAR EDEMA WITH OPTICAL COHERENCE TOMOGRAPHY [J].
HEE, MR ;
PULIAFITO, CA ;
WONG, C ;
DUKER, JS ;
REICHEL, E ;
RUTLEDGE, B ;
SCHUMAN, JS ;
SWANSON, EA ;
FUJIMOTO, JG .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (08) :1019-1029
[6]   Decision support system for the detection and grading of hard exudates from color fundus photographs [J].
Jaafar, Hussain F. ;
Nandi, Asoke K. ;
Al-Nuaimy, Waleed .
JOURNAL OF BIOMEDICAL OPTICS, 2011, 16 (11)
[7]   Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates [J].
Jeon, Sohee ;
Lee, Won Ki .
CLINICAL OPHTHALMOLOGY, 2014, 8 :1479-1486
[8]   Effect of Intravitreal Bevacizumab Based on Optical Coherence Tomography Patterns of Diabetic Macular Edema [J].
Kim, Moosang ;
Lee, Pyung ;
Kim, Younggyun ;
Yu, Seung-Young ;
Kwak, Hyung-Woo .
OPHTHALMOLOGICA, 2011, 226 (03) :138-144
[9]   THE WISCONSIN EPIDEMIOLOGIC-STUDY OF DIABETIC-RETINOPATHY .3. PREVALENCE AND RISK OF DIABETIC-RETINOPATHY WHEN AGE AT DIAGNOSIS IS 30 OR MORE YEARS [J].
KLEIN, R ;
KLEIN, BEK ;
MOSS, SE ;
DAVIS, MD ;
DEMETS, DL .
ARCHIVES OF OPHTHALMOLOGY, 1984, 102 (04) :527-532
[10]  
KLEIN R, 1995, OPHTHALMOLOGY, V102, P7